Eurazeo PME, formerly known as OFI Private Equity Capital. Eurazeo PME invests equity and mezzanine capital in secondary buyout transactions of unlisted French companies. The Firm looks for opportunities valued between €50 and €200 million. Areas of interest include chemicals, financial services, consumer services, retail, manufacturing, distribution, and life science. Eurazeo PME was formed in 1997 and is based in Paris.
Join Mergr to view the latest updates and news from Paris-based Eurazeo PME.
In the last 3 years, Eurazeo PME has acquired 4 companies. It has also invested in 3 others.
Eurazeo PME’s most common sectors for investment are chemicals (9%) and life science (6%). The Firm’s most common investment types include secondary buyout (40%) and buyout (lbo, mbo, mbi) (38%). In total, Eurazeo PME has invested in 1 US state and 9 different countries. Its largest (disclosed) acquisition occurred in 2007 when it acquired Elis AS for $2.3B.
In the last 3 years, Eurazeo PME has exited 4 companies. The Firm’s most common exit type is secondary buyout (58%). Eurazeo PME’s largest (disclosed) exit occurred in 2005 when it sold Terreal SAS for $969M.
Join Mergr to view Eurazeo PME’s full profile and discover more middle-market private equity firms just like it.
No obligation. Cancel anytime.